Page last updated: 2024-09-04

glucagon and natriuretic peptide, brain

glucagon has been researched along with natriuretic peptide, brain in 1 studies

Compound Research Comparison

Studies (glucagon)	Trials (glucagon)	Recent Studies (post-2010) (glucagon)	Studies (natriuretic peptide, brain)	Trials (natriuretic peptide, brain)	Recent Studies (post-2010) (natriuretic peptide, brain)
26,039	1,498	3,054	16,317	1,867	8,887

Protein Interaction Comparison

Protein	Taxonomy	glucagon (IC50)	natriuretic peptide, brain (IC50)
Atrial natriuretic peptide receptor 1	Homo sapiens (human)		0.006

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avogaro, A; Fadini, GP	1

Reviews

1 review(s) available for glucagon and natriuretic peptide, brain

Article	Year
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors. British journal of clinical pharmacology, 2018, Volume: 84, Issue:8 Topics: Cardiovascular Diseases; Cardiovascular System; Chemokine CXCL12; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin; Natriuretic Peptide, Brain; Neuropeptide Y; Practice Guidelines as Topic; Proteolysis; Receptors, CXCR4	2018

Article

Year

The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors.

British journal of clinical pharmacology, 2018, Volume: 84, Issue:8

Topics: Cardiovascular Diseases; Cardiovascular System; Chemokine CXCL12; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin; Natriuretic Peptide, Brain; Neuropeptide Y; Practice Guidelines as Topic; Proteolysis; Receptors, CXCR4

2018